₹1,668
▼ -30.92 -1.82%
As of 09 Sept 2026 · delayed
NSE Listed
Aurobindo Pharma Ltd. (AUROPHARMA)
Volume: 6,00,583Avg Vol 1W: 7,37,451.4Avg Vol 1M: 8,31,914.252W Range:₹1,036₹1,717
Key Ratios
Checked 6h agoMarket Cap₹97,751 Cr
Current Price₹1,668
Previous Close₹1,698.92
High / Low (52w)₹1,717 / ₹1,036
Volume6,00,583
Avg Vol (1W)7,37,451.4
Avg Vol (1M)8,31,914.2
Stock P/E25.85
Book Value₹658.53
Dividend Yield24%
ROE9.25%
ROA6.34%
Revenue (TTM)₹34,145 Cr
Revenue Growth9.4%
Profit Margin10.7%
Total Debt₹1,559 Cr
Shares Outstanding58 Cr
Face Value₹1
EPS (TTM)₹65.71
P/B2.57
Debt / Equity0.23
50 DMA₹1,605.74
200 DMA₹1,391.29
Day change-1.82%
Price Chart
₹1,668▲ 58.81% · 1Y
2025-09-102026-09-09
20-day avg volume: 8.3L shares
Pros
- Pays a dividend yield of 24.0%.
- Company is almost debt-free.
Cons
- Revenue fell 15% YoY.
Quarterly Results
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹7,796 Cr | ₹7,979 Cr | ₹8,382 Cr | ₹7,868 Cr | ₹8,286 Cr | ₹8,646 Cr | ₹8,853 Cr | ₹9,150 Cr |
| EBITDA | ₹1,320 Cr | ₹1,317 Cr | ₹1,482 Cr | ₹1,303 Cr | ₹1,370 Cr | ₹1,496 Cr | ₹1,391 Cr | ₹1,658 Cr |
| Net Profit | ₹817 Cr | ₹846 Cr | ₹903 Cr | ₹825 Cr | ₹848 Cr | ₹910 Cr | ₹921 Cr | ₹1,033 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹32,346 Cr | ₹2,732 Cr | ₹2,848 Cr | ₹2,790 Cr | ₹2,747 Cr | ₹2,787 Cr | ₹34,145 Cr | ₹2,800 Cr |
| EBITDA | ₹5,555 Cr | ₹617 Cr | ₹810 Cr | ₹813 Cr | ₹848 Cr | ₹924 Cr | ₹5,560 Cr | ₹1,055 Cr |
| Net Profit | ₹3,486 Cr | ₹408 Cr | ₹559 Cr | ₹581 Cr | ₹582 Cr | ₹692 Cr | ₹3,505 Cr | ₹737 Cr |
| EPS | 59.81 | — | — | — | — | — | 60.34 | — |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹26,454 Cr | ₹28,928 Cr | ₹33,854 Cr | ₹33,922 Cr | ₹39,890 Cr | ₹45,072 Cr | ₹49,785 Cr | ₹58,502 Cr |
| Total Liabilities | ₹12,562 Cr | ₹12,103 Cr | ₹11,925 Cr | ₹9,348 Cr | ₹13,038 Cr | ₹15,221 Cr | ₹17,138 Cr | ₹20,619 Cr |
| Equity | ₹13,892 Cr | ₹16,825 Cr | ₹21,929 Cr | ₹24,574 Cr | ₹26,852 Cr | ₹29,851 Cr | ₹32,647 Cr | ₹37,883 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹2,421 Cr | ₹5,142 Cr | ₹4,614 Cr | ₹6,275 Cr | ₹3,104 Cr | ₹4,201 Cr | ₹5,656 Cr | ₹7,358 Cr |
| Investing | ₹-2,903 Cr | ₹-1,568 Cr | ₹599 Cr | ₹-3,212 Cr | ₹-3,978 Cr | ₹-4,256 Cr | ₹-1,876 Cr | ₹-3,459 Cr |
| Financing | ₹1,919 Cr | ₹-1,947 Cr | ₹-1,365 Cr | ₹-2,969 Cr | ₹1,814 Cr | ₹800 Cr | ₹120 Cr | ₹-1,269 Cr |
| Free Cash Flow | ₹2,421 Cr | ₹5,142 Cr | ₹4,614 Cr | ₹6,275 Cr | ₹3,104 Cr | ₹4,201 Cr | ₹5,656 Cr | ₹7,358 Cr |
Shareholding
Promoter 51.88% Institutions 41.48% Public 6.64%
Efficiency & Working Capital
ROCE11.8%
Interest Coverage14.3
Dividend Payout—
Debtor Days77 d
Inventory Days131 d
Payable Days60 d
Cash Conversion Cycle147 d
Working Capital Days208 d
Shareholding Details
As of 2026-06-30
Promoter51.9%
FII16.4%
DII25.1%
Institutions41.5%
Public6.6%
Promoter Pledge13.8%
No. of Shareholders2,39,073
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 51.8% | 51.8% | 51.8% | 51.8% | 51.8% | 51.8% | 51.8% | 51.8% | 51.8% | 51.8% | 51.8% | 51.9% |
| FIIs | 22.5% | 20.7% | 18% | 16.7% | 16.6% | 16.3% | 15.3% | 14.4% | 14.2% | 13.9% | 15.2% | 16.4% |
| DIIs | 17.9% | 20.2% | 23.3% | 24.8% | 25.1% | 25.2% | 26.2% | 26.9% | 27.6% | 27.7% | 25.9% | 25.1% |
| Public | 7.8% | 7.2% | 6.9% | 6.7% | 6.5% | 6.7% | 6.6% | 6.9% | 6.4% | 6.6% | 7.1% | 6.6% |
| Promoter Pledge | 19.6% | 18.9% | 20.9% | 20.9% | 20.4% | 17.8% | 16.9% | 17.1% | 17.5% | 17.5% | 23.7% | 13.8% |
| No. of Shareholders | 2,59,638 | 2,41,944 | 2,44,575 | 2,38,622 | 2,48,488 | 2,57,962 | 2,69,323 | 2,72,208 | 2,47,662 | 2,36,859 | 2,41,298 | 2,39,073 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Rpr Sons Advisors Private Limited, Mrs.p.suneela Rani (jointly Holding) | Shareholding of Promoter and Promoter Group | 33.5% | 19.30 Cr |
| Quant Mutual Fund | Public Shareholding | 5% | 2.85 Cr |
| Kambam Nithyananda Reddy | Shareholding of Promoter and Promoter Group | 4.4% | 2.51 Cr |
| Sbi Large & Midcap Fund | Public Shareholding | 3.6% | 2.05 Cr |
| Kirthi Reddy Kambam | Shareholding of Promoter and Promoter Group | 3.5% | 1.99 Cr |
| Hdfc Mutual Fund | Public Shareholding | 3.2% | 1.85 Cr |
| Venkata Ramprasad Reddy Penaka | Shareholding of Promoter and Promoter Group | 3.1% | 1.77 Cr |
| Life Insurance Corporation Of India | Public Shareholding | 2.9% | 1.69 Cr |
| Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.ltd. (jointly Holding) | Shareholding of Promoter and Promoter Group | 2.9% | 1.64 Cr |
| Nps Trust - A/c Sbi Pension Fund Scheme - Nps Tier | Public Shareholding | 2.7% | 1.58 Cr |
| M Sivakumaran | Shareholding of Promoter and Promoter Group | 2.5% | 1.42 Cr |
| Kambam Spoorthi | Shareholding of Promoter and Promoter Group | 1.2% | 68,83,414 |
| Kottamanchi Rajeswari | Shareholding of Promoter and Promoter Group | 0.3% | 17,94,100 |
| M Sumanth Kumar Reddy | Shareholding of Promoter and Promoter Group | 0.3% | 15,72,477 |
| Trident Chemphar Limited | Shareholding of Promoter and Promoter Group | 0.1% | 7,75,957 |
| Axis Clinicals Limited | Shareholding of Promoter and Promoter Group | 0.1% | 6,46,682 |
| Prasada Reddy Kambham | Shareholding of Promoter and Promoter Group | 0.1% | 2,95,976 |
| Suneela Rani Penaka | Shareholding of Promoter and Promoter Group | 0% | 1,27,765 |
| Kambam Surya Prakash Reddy | Shareholding of Promoter and Promoter Group | 0% | 7,380 |
| Penaka Neha Reddy | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Kottamanchi Rajeswari | 2,00,000 | 11.2% | 2026-06-30 |
| Kambam Nithyananda Reddy | 96,50,000 | 38.4% | 2026-06-30 |
| Prasada Reddy Kambham | 1,00,000 | 33.8% | 2026-06-30 |
| M Sumanth Kumar Reddy | 8,00,000 | 50.9% | 2026-06-30 |
| Kirthi Reddy Kambam | 27,00,000 | 13.6% | 2026-06-30 |
| Kambam Spoorthi | 4,00,000 | 5.8% | 2026-06-30 |
| Rpr Sons Advisors Private Limited, Mrs.p.suneela Rani (jointly Holding) | 2.72 Cr | 14.1% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| M R Kumar | Chairman & Independent Directo | 2026 |
| Kambam Nityananda Reddy | Vice Chairman & M.D. | 2026 |
| M Madan Mohan Reddy | E D & Wholetime Director | 2026 |
| P V Ramprasad Reddy | Non Executive Director | 2026 |
| Penaka Sarath Chandra Reddy | Non-Exec & Non-Independent Dir | 2026 |
| Girish Paman Vanvari | Independent Non Exe. Director | 2026 |
| Santanu Mukherjee | Independent Non Exe. Director | 2026 |
| Satakarni Makkapati | Non-Exec & Non-Independent Dir | 2026 |
| Punita Kumar Sinha | Independent Non Exe. Director | 2026 |
| B Adi Reddy | Company Sec. & Compli. Officer | 2026 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| API | ₹592 Cr | 5.3% |
| Formulations | ₹10,580 Cr | 94.7% |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹1,200 Cr | 10.7% |
| USA | ₹5,021 Cr | 44.9% |
| Europe | ₹3,568 Cr | 31.9% |
| Rest of the world | ₹1,382 Cr | 12.4% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹1 | 454 | 58 | 58 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-08-05 | Board Meetings | — |
| buyback | 2026-04-29 | ₹1475 max | — |
| dividend | 2025-08-08 | ₹4 (400%) | Interim |
| forthcoming | — | Book Closure | AGM |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 30,454 | 27 | 68 | 20 | 632 | 31,202 |
| 2026 | 11,502 | 8 | 13 | 0 | 90 | 11,614 |
| 2026 | 10,529 | 19 | 55 | 20 | 541 | 11,164 |
Insider / Designated-Person Trades
30 recent disclosure(s)
RPR Sons Advisors Pvt.Ltd. Mrs.P.Suneela Rani jointly holdingRevoke · 1,16,35,862
RPR Sons Advisors Pvt.Ltd. Mrs.P.Suneela Rani jointly holdingPledge · 1,67,00,000
A.Janardhana KamathDisposal · 6,000
Pavankumar PSDisposal · 1,000
Chandrasekhar Reddy KandatiDisposal · 2,000
RPR Sons Advisors Pvt.Ltd. Mrs.P.Suneela Rani jointly holdingRevoke · 23,00,000
Substantial Acquisitions (SAST)
4 disclosure(s)
Market07/06/2024 · 2,00,000
Market24/11/2021 · 79,000
Inter-se Transfer / Gift30/09/2021 · 1,30,000
Inter-se Transfer / Gift30/09/2021 · 1,30,000
Company Information
Incorporated1986
ChairmanM R Kumar
AuditorDeloitte Haskins & Sells
Investor Email[email protected]; [email protected]
📍 Plot No 2 Maitrivihar, Behind Maithri Vanam Ameerpet, Hyderabad, Telangana, 500038
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Atul Auto LimitedAU Small Finance Bank Ltd.Augmont Enterprises Ltd.Auri Grow India LimitedAurionpro Solutions Ltd.Auro Impex & Chemicals LimitedAurum PropTech LimitedAditya Ultra Steel Ltd.AuSom Enterprise LimitedAustin Engineering Co. LimitedAutomotive Axles LimitedAutoline Industries Ltd.All “A” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search